Mytenslo A Tablet
Marketer
Mylan Pharmaceuticals Pvt Ltd - A Viatris Company
Salt Composition
Telmisartan (40mg) + Amlodipine (5mg)
Overview Mytenslo A Tablet
Mytenslo A Tablet combines two active ingredients to effectively manage hypertension. It reduces blood pressure by widening blood vessels, easing the heart's workload. This lowers the risk of stroke and heart attack. Mytenslo A can be taken with or without food, but consistent daily dosing, as directed by your physician, is crucial. Dosage is individualized based on your health and response. Continued use, even when feeling well, is vital for sustained blood pressure control and risk reduction; discontinue only under your doctor's guidance. Lifestyle modifications – regular exercise, smoking cessation, and a low-sodium, low-fat diet – enhance its effectiveness. Common side effects include ankle or foot swelling, headache, drowsiness, dizziness, fatigue, and indigestion. Drowsiness and dizziness may impair alertness; avoid driving or tasks requiring focus until the effects are known. Report persistent or bothersome side effects to your doctor. Inform your physician of any kidney or liver issues, or severe dehydration, before starting treatment. Pregnant or nursing individuals should seek medical advice prior to use. Regular blood pressure monitoring and potential kidney function tests are necessary during treatment.
Primary Ingredients of Mytenslo A Tablet
No information provided. Please provide the text you wish to be rephrased.
Uses of Mytenslo A Tablet
Managing Elevated Blood Pressure
Major Benefits of Mytenslo A Tablet:
Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Mytenslo A Tablet can be consumed with or without food, though consistent daily timing is recommended.
Common Side effects of Mytenslo A Tablet:
- Sleepiness
- Ankle swelling
- Headache
- Dizziness
- Tiredness
- Upset stomach
- Peripheral edema
- Sudden decrease in blood pressure
How to use Mytenslo A Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for Mytenslo A Tablet. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Consumption with or without food is acceptable, however, consistent daily timing is recommended.
How Mytenslo A Tablet works:
Mytenslo A Tablet contains Telmisartan, an angiotensin II receptor antagonist, and Amlodipine, a calcium channel blocker. These medications act synergistically to widen blood vessels and improve cardiac output, resulting in a significant reduction in blood pressure.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Mytenslo A Tablet is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Using Mytenslo A Tablets during pregnancy is inadvisable due to confirmed risks to the fetus. Nevertheless, a physician might exceptionally prescribe it in life-threatening emergencies where the potential benefits outweigh the known hazards. Seek medical advice before using this medication.
Breast feedingSAFE IF PRESCRIBED
Based on available data from human studies, Mytenslo A Tablet appears to pose a negligible risk to infants during breastfeeding.
DrivingUNSAFE
Driving ability may be impaired by Mytenslo A Tablet side effects. These can include dizziness, headaches, nausea, or fatigue, potentially impacting concentration and safe driving.
KidneySAFE IF PRESCRIBED
Patients with kidney disease can safely take Mytenslo A Tablet without requiring a change in dosage.
LiverCAUTION
Individuals with hepatic impairment should exercise caution when using Mytenslo A Tablet. Dosage modification of Mytenslo A Tablet may be necessary. Physician consultation is advised.
What if you forget to take Mytenslo A Tablet :
Should you forget a Mytenslo A Tablet dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Mytenslo A Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | HEART |



